Abiopharma

News list

Murphy Matthew B. 🟢 acquired 20.0K shares of Nautilus Biotechnology, Inc. (NAUT) at $0.64 Transaction Date: Sep 04, 2025 | Filing ID: 000003

Full text

News bot Sept. 5, 2025, 10:34 p.m.
🔍 Murphy Matthew B. (Executive)

Company: Nautilus Biotechnology, Inc. (NAUT)

Report Date: 2025-09-04
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 20,000
- Total shares held: 1,250
Detailed Transactions and Holdings:
- Acquired 20,000 shares of Common Stock at $0.6429 per share (Direct)
  Date: 2025-09-04 | Code: P | equity_swap_involved: 0 | shares_owned_after: 74,140.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-04 | Code: H | shares_owned_after: 1,250.00
Footnotes:
- F1: Shares held by the Murphy Family Trust. The reporting person is the Trustee of the Murphy Family Trust.